$533.760
-9.768 (-1.83%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
MDGL 相似图表分析预测
Alphio's MDGL stock price prediction model matches the current Madrigal Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $538.88 (+0.96%). The 1-week path is $536.38 (+0.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Madrigal Pharmaceuticals Inc 股票吗？
Madrigal Pharmaceuticals Inc is a good buy right now due to its strong sales growth momentum, with Rezdiffra achieving $364.3 million in Q2 sales, reflecting a 71% year-over-year increase. Additionally, the current price of $533.76 is significantly below the analyst price targets, which range from $605 to $962, indicating substantial upside potential. The main risk is the forward P/E ratio of 666.67, suggesting high expectations that may not be met if growth slows.
MDGL 股价于 Friday 收于 $533.76，此前下跌 -1.83%
Madrigal Pharmaceuticals Inc (MDGL) last closed at $533.76, losing -1.83%. These facts feed the 1-day and 1-week MDGL price prediction above.
分析师一致预期
Madrigal Pharmaceuticals Inc（MDGL）：买入 3、持有 0、卖出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
预测驱动因素
Madrigal Pharmaceuticals Inc（MDGL）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似图表形态
近期走势与 MDGL 最接近的股票，按相似度排序。
MDGL 季节性分析
Historically the probability of a positive August return for MDGL is 65.08%. November offers the highest probability of a positive month at 100.00%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。